Femasys (FEMY) Cash from Investing Activities Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -528.34% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -4.51% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -82.56% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 40.11% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | -6.30% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -420.31% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -104.07% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -14.95% |
| 10 | Femasys | 22.30 Mn | 16.91 Mn | - | 18.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.08% |
| Dec 31, 2025 | -77.84% |
| Sep 30, 2025 | 45.50% |
| Jun 30, 2025 | 53.15% |
| Mar 31, 2025 | -7.15% |
| Dec 31, 2024 | -146.36% |
| Sep 30, 2024 | -1,519.60% |
| Jun 30, 2024 | -228.78% |
| Mar 31, 2024 | -912.92% |
| Dec 31, 2023 | 52.17% |
| Sep 30, 2023 | -46.54% |
| Jun 30, 2023 | 63.97% |
| Mar 31, 2023 | 92.61% |
| Dec 31, 2022 | 20.86% |
| Sep 30, 2022 | 89.45% |
| Jun 30, 2022 | -1,296.18% |
| Dec 31, 2021 | -703.19% |
| Sep 30, 2021 | -653.54% |